A detailed history of Garner Asset Management Corp transactions in Novo Nordisk A S stock. As of the latest transaction made, Garner Asset Management Corp holds 1,572 shares of NVO stock, worth $175,985. This represents 0.11% of its overall portfolio holdings.

Number of Shares
1,572
Previous 1,580 0.51%
Holding current value
$175,985
Previous $203,000 10.34%
% of portfolio
0.11%
Previous 0.1%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 12, 2024

SELL
$122.71 - $146.91 $981 - $1,175
-8 Reduced 0.51%
1,572 $224,000
Q4 2023

Feb 14, 2024

BUY
$87.78 - $105.45 $138,692 - $166,611
1,580 New
1,580 $163,000
Q1 2023

May 15, 2023

BUY
$132.34 - $159.14 $181,305 - $218,021
1,370 New
1,370 $218,000

Others Institutions Holding NVO

About NOVO NORDISK A S


  • Ticker NVO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,257,289,984
  • Market Cap $253B
  • Description
  • Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...
More about NVO
Track This Portfolio

Track Garner Asset Management Corp Portfolio

Follow Garner Asset Management Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Garner Asset Management Corp, based on Form 13F filings with the SEC.

News

Stay updated on Garner Asset Management Corp with notifications on news.